EN DE
Watch NetraMark Holdings Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

NetraMark Holdings Inc. (AIAI) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of NetraMark Holdings Inc. stock C$0.32, price C$0.58, that is 44.0% below the price, quality 41 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare CA · ISIN CA64119M1059

NH NetraMark Holdings Inc. logo Thin data Nov 10, 2026

NetraMark Holdings Inc.

AIAI · TO
Weakest Setup

Our calculation puts a fair price 44% below what the stock costs today.

Quality 41/100
Expensive Growth (revenue 3y +56.4 %/yr in CAD)
Revenue last quarter 69% below a year ago.
Fair value C$0.3247 · Strongly overvalued
Negative free cash flow
Trails peers (0/6)
Narrow moat 23/100
Thin data
Estimate
Watch NetraMark Holdings Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

C$1.11 C$0.5000 Fair Value C$0.3247 Feb 2026 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

9‑month range C$0.5000 – C$1.11 · fair‑value band C$0.2435 – C$0.4059 · the C$0.5800 price screens above the C$0.3247 fair value. As of Nov 10, 2026.

Follow NetraMark Holdings in your weekly email

Every Wednesday you see whether NetraMark Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide.

Show moreShow less

It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023.

NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

Stock analysis

NetraMark Holdings Inc. (AIAI) currently trades at C$0.5800, while our estimate is C$0.3247, 44% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: C$0.2435 (bear) to C$0.4059 (bull), the price of C$0.5800 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

NetraMark Holdings Inc. reported revenue of C$433K in FY2025 versus C$113K in FY2022, a compound +56.4%/yr. Reported net income was −C$5.2M in FY2025.

Key figures

Market cap C$54.6M (≈ $38.5M) Micro · P/S ratio 90.6 · EPS (TTM) C$−0.0700 · Return on equity −315% · Return on assets (EBIT) −669% (4-year average) · Operating margin −337% · Revenue (TTM) C$606K · Revenue growth (YoY) −69.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (medium confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at −35% fair-value upside, at −44%, AIAI screens richer than that median.

Fair Value

Bear C$0.2435 Fair Value C$0.3247 Bull C$0.4059
Price C$0.5800 · Downside -44.0%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 41/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 1
How much profit the company makes from its sales and capital
Quality Growth 25
Are margins and returns getting better?
Cashflow 29
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 15
How calm the share price moves, does not count
Price momentum 13
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 1
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−5.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+56.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−7,017.6% (2022) → −1,216.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

AIAI screens overvalued: fair value 44% below the price. Compare with Veeva Systems Inc →

Compare NetraMark Holdings Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 141 stocks

Beats the industry median on 0/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 41 · Below median
Fair Value upside −44.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −69.2% · Bottom 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 29.77× · Priciest 25%
P/S (12 months) 90.12× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Doximity, Inc DOCS $32.42 $36.16 +12% vs AIAI
Veeva Systems Inc VEEV $305.55 $337.04 +10% vs AIAI
HealthEquity, Inc HQY $103.54 $112.32 +8% vs AIAI
Waystar Holding WAY $29.30 $29.10 −1% vs AIAI
Tempus AI, Inc TEM $80.54 $52.58 −35% vs AIAI
HeartFlow, Inc HTFL $55.80 $34.82 −38% vs AIAI
Hinge Health, Inc HNGE $123.23 $51.25 −58% vs AIAI
Pro Medicus Limited PME A$207.31 A$85.12 −59% vs AIAI
BrightSpring Health Services, Inc BTSG $72.49 $25.72 −65% vs AIAI
XtalPi Holdings 2228 HK$6.37 HK$1.53 −76% vs AIAI

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

NetraMark Holdings Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "NetraMark Holdings Inc. Fair Value". https://www.fairvalue-calculator.com/stock/AIAI

Frequently asked questions

Is NetraMark Holdings Inc. (AIAI) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is C$0.3247 versus a price of C$0.5800, about 44% lower (overvalued).
What is the fair value of AIAI?
Our estimate for NetraMark Holdings Inc. is C$0.3247 (as of Nov 10, 2026), built from audited fundamentals. The current price: C$0.5800.
What is the quality score of AIAI?
NetraMark Holdings Inc. has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for NetraMark Holdings Inc. (AIAI)?
Our calculated price target is the estimate of C$0.3247 (as of Nov 10, 2026). Cautious scenario C$0.2435, optimistic scenario C$0.4059. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the NetraMark Holdings Inc. stock forecast for 2026?
Our estimate puts fair value at C$0.3247, about 44% lower versus a price of C$0.5800 (overvalued). Cautious scenario C$0.2435, optimistic scenario C$0.4059. The calculation is refreshed regularly with new filings.
What is the revenue of NetraMark Holdings Inc. (AIAI)?
NetraMark Holdings Inc. reported trailing-twelve-month revenue of about C$606K (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of NetraMark Holdings Inc. (AIAI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For NetraMark Holdings Inc. it is C$0.3247 per share (as of Nov 10, 2026), against a price of C$0.5800.
Is NetraMark Holdings Inc. stock overvalued or undervalued in 2026?
As of Nov 10, 2026, AIAI trades above its calculated fair value: price C$0.5800, fair value C$0.3247, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AIAI?
No. The price is what the market pays today (C$0.5800); the fair value is what the company's own numbers justify (C$0.3247). For NetraMark Holdings Inc. the two are C$0.2553 per share apart. That gap is exactly why we show both numbers side by side.
How much is NetraMark Holdings Inc. worth?
The market values NetraMark Holdings Inc. at about C$54.6M (market capitalisation, as of Nov 10, 2026). Per share that is C$0.5800; our models calculate a fair value of C$0.3247 per share.
What do the bullish and bearish scenarios say about AIAI?
Our models span a range for NetraMark Holdings Inc.: cautious scenario C$0.2435, base C$0.3247, optimistic C$0.4059 per share (as of Nov 10, 2026, price C$0.5800). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of NetraMark Holdings Inc. (AIAI)?
Balance-sheet figures for NetraMark Holdings Inc. (as of Nov 10, 2026): return on equity −314.7%. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
Which stocks are comparable to NetraMark Holdings Inc.?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is NetraMark Holdings Inc. stock attractive at the current price?
The data as of Nov 10, 2026: price C$0.5800, calculated fair value C$0.3247 (−44%), Quality Score 41/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. NetraMark Holdings Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of NetraMark Holdings Inc. (AIAI)?
The closing price on Nov 10, 2026 was C$0.5800. Our estimate is C$0.3247, about 44% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with NetraMark Holdings Inc. right now?
The price sits above even our optimistic bull case (C$0.4059). The favourable scenario is already priced in. Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of NetraMark Holdings Inc.

How large is the market capitalisation of NetraMark Holdings Inc. (AIAI)?
The market capitalisation of NetraMark Holdings Inc. is C$54.6M (≈ $38.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of NetraMark Holdings Inc. (AIAI)?
The price-to-sales ratio of NetraMark Holdings Inc. is 90.6 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of NetraMark Holdings Inc. (AIAI)?
Earnings per share at NetraMark Holdings Inc. are C$−0.0700. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of NetraMark Holdings Inc. (AIAI)?
The return on equity (ROE) of NetraMark Holdings Inc. is −315% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of NetraMark Holdings Inc. (AIAI)?
On an EBIT basis the return on assets of NetraMark Holdings Inc. is −669% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of NetraMark Holdings Inc. (AIAI)?
The operating margin of NetraMark Holdings Inc. is −337% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at NetraMark Holdings Inc. (AIAI)?
Revenue at NetraMark Holdings Inc. is growing −69.2% versus a year earlier (3y avg +56.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does NetraMark Holdings Inc. (AIAI) generate?
The free cash flow of NetraMark Holdings Inc. is −C$3.8M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch NetraMark Holdings Inc. in the live analysis

One click puts NetraMark Holdings Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.